All posts by imreal

NEWNESS Puts the CARE in Skincare with Skincare Summer School


NEWNESS Puts the CARE in Skincare with Skincare Summer School

“As an esthetician, I’m happy to be part of this platform that helps provide fellow skincare and beauty enthusiasts a safe place to ask questions, learn in fun ways and support each other,” – Jordan Samuel Pacitti, founder and CEO of Jordan Samuel Skin.

NEWNESS, a social livestreaming platform that celebrates authenticity in the beauty industry, today announced Skincare Summer School — a new series that is breaking down barriers (just not skin barriers!)

The three month program, hosted exclusively on NEWNESS, is just one of the ways the platform is empowering creators, viewers and brands to crowdsource their shared knowledge and experiences in an effort to bring genuine human connection and trust back to social media. Skincare Summer School welcomes all opinions and recommendations as a valued part of the lesson plan.

“A word I’d use to describe NEWNESS is refreshing,” says aspiring esthetician and NEWNESS creator Melody Jones (also known as Melroseglow online). “It’s a safe space to connect with other beauty lovers that feels more intimate than other social media platforms. With Skincare Summer School, I get to engage with brands in this same approachable way.”

Through Skincare Summer School, participants are given the opportunity to chat with leading skincare brands via fun and educational content, alongside like-minded “skintellectuals.” Other benefits include livestreams from relatable creators, challenges, giveaways, and so much more.

“One of our goals with Skincare Summer School is to help bridge the gap in trust between beauty seekers and brands,” said Jenny Qian, Founder and CEO of NEWNESS. “Social media has helped to cultivate a new generation of skincare lovers— myself included!—but it’s still hard to know if that product or technique is right for me. I’ve always wanted a place online where I could go to have real discussions with brands and other skincare lovers who were just as passionate about skincare as me. We’re thrilled that NEWNESS be that home by providing an intimate space for the beauty community to meet and converse with each other, other creators, and now their favorite brands in an authentic, jugement-free way.”

“And for brands, studies show that 81% of consumers say that trust is a deciding factor in purchase decisions,” continued Qian. “We want to help brands build trust and create long-term relationships with beauty seekers by offering them a platform to spark authentic dialogue that’s intimate and transformative.”

Beauty and skincare lovers can tune in for:

  • Deep Dive into Cleansers and Retinols with Jordan Samuel Pacitti of Jordan Samuel Skin (8/16 at 6pm ET)
  • Debunking Fragrance Myths with I Dew Care (8/25 at 6pm ET)
  • Finding your Nighttime Skincare routine with Glow Recipe (9/7 at 5pm ET)
  • Self Care Rituals with Superegg founder Erica Choi (9/15 at 6pm ET)
  • Affordable & Fun Skincare Tools with I Dew Care (9/22 at 6pm ET)


If you missed it, you can watch:

  • Indie Lee’s Top 5 Skincare Secrets you need to know, here.
  • An Introduction to Experiment Beauty & Reusable Face Mask 101 with founder Lisa Guerrera, here.
  • Korean Wellness Focused Summer Skincare Tips with Riley House founders Mina Jang & Grace Son, here.
  • Lymphatic Drainage Techniques with Noelle Valera from Kana Skincare, here.


OSEA, Wander Beauty, Matter of Fact, and Kiramoon are also scheduled to participate, with more brands being added each week!

“As an esthetician, I’m happy to be part of this platform that helps provide fellow skincare and beauty enthusiasts a safe place to ask questions, learn in fun ways and support each other,” said Jordan Samuel Pacitti, founder and CEO of Jordan Samuel Skin. “I can’t wait to share tips and tricks that I have learned in both theater dressing rooms and skin treatment rooms as part of NEWNESS’s Summer School, starting with proper cleansing and retinol usage—two of the foundational aspects of a solid skincare routine.”

As part of the program, products from the participating Skincare Summer School brands will be included in a monthly skincare box available to qualifying creators—allowing them to continue the conversation long after the brand livestreams have ended.

“The concept is so fun, and you can just give your honest opinions without any obligations or approval needed,” shared aspiring esthetician and NEWNESS creator Rachel Russell (known as skincarewithrae online). You’re here to talk about products and brands, but you get to be yourself!”

Click here to learn more and enroll in Skincare Summer School.

About NEWNESS

NEWNESS is a social livestreaming platform created for beauty lovers, by beauty lovers. Born from the belief that there is a special magic in livestreaming, NEWNESS empowers its community to create meaningful moments together by celebrating all things beauty.

Whether they’re going live with their daily makeup routine or connecting with other beauty enthusiasts in the chat, NEWNESS creators and viewers are empowered to authentically express themselves.

Backed by leading investors including Sequoia Capital, NEWNESS’ mission is to provide the beauty community with an inclusive space for exploration, connection and conversation. Where one might see an audience to engage, we see a community of best friends inspiring one another. See you in the chat! Learn more at http://www.newness.com.

Share article on social media or email:

The Top 25 Healthcare Technology Leaders of Connecticut for 2022


The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology Leaders of Connecticut for 2022. Connecticut is home to some of the best healthcare services in the country, coming in at #3 in U.S. News & World Report’s rankings measuring how well states are meeting citizens’ health care needs. It is also home to some of the most innovative, cutting-edge healthcare technology companies, which are revolutionizing the way we tackle health challenges of all types. The awardees on this list have been responsible for leading these companies—not only to profitability, but to life-changing breakthroughs.

As Vice President and Head of Clinical Development, Scott Rottinghaus is driving Alexion Pharmaceuticals toward its goal of transforming the lives of people living with rare diseases and devastating conditions. CEO Vlad Coric’s Biohaven Pharmaceuticals is on its way to using certain glutamate modulating agents in the treatment of neuropsychiatric disorders. And Founder and CEO Eric Schadt’s Sema4 is transforming healthcare by using AI and machine learning to build dynamic models of human health and define optimal, individualized health trajectories.

Being sandwiched between the major metropolitan areas of New York City and Boston, Connecticut can sometimes be overlooked, but the leaders on this year’s list and the company’s they represent demonstrate that Connecticut is a powerhouse in its own right when it comes to the healthcare technology industry. Please join us in celebrating The Top 25 Healthcare Technology Leaders of Connecticut for 2022.

Scott Rottinghaus (Alexion Pharmaceuticals, Inc.), Jean-Claude Marshall (Moderna), Susie Robinson (Signant Health), Henry Izawa (FUJIFILM Healthcare Americas Corporation), Vlad Coric (Biohaven Pharmaceuticals), Lisa Dunkle (NOVAVAX INC), Eric Schadt (Sema4), Sean Mackay (IsoPlexis), Steve Weiss (Arvinas), Angela Cacace (Arvinas), Richard Blackburn (Azurity Pharmaceuticals), Saqib Islam (SpringWorks Therapeutics), Bob Reinhardt (Defibtech, LLC), Kristin King (Defibtech, LLC), Peter Arn (ROM Technologies Inc), Nicole Sandford (Aspira Women’s Health), Henri Lichenstein (Drug Farm Inc), Vimal Mehta (BioXcel Corporation), Vikram Butani (KUBTEC Medical Imaging), Lan Li (WuXi AppTec), Bo Qu (TCG GreenChem Inc.), Bryan Jennings (TME Pharma), Bridget Martell (Artizan Biosciences, Inc.), Reza Amin (Bastion Health), Sasha Bakhru (Perosphere Technologies).

The full article can be read at https://thehealthcaretechnologyreport.com/

About The Healthcare Technology Report

The Healthcare Technology Report provides market research and insights, business news, investment activity updates, and important corporate developments related to the healthcare technology sector. Based in New York City, the firm is run by a seasoned team of editors, writers, and media professionals highly knowledgeable on healthcare technology and the various companies, executives, and investors that make up the sector.

Share article on social media or email:

Chronic Illness Patient Advocates with New Book On ‘Dealing with Disease’ in Today’s Healthcare System Where Doctors Can’t Help


“I believe in self-advocacy and created a collaborative joint effort with doctors, advocates, and scientists on the edge of research to bring this patient community resource to life,” Cox says.

Christie Cox, a patient and advocate who suffers from hypermobile Ehlers Danlos syndrome (EDS), announced today the release of her new book titled Holding It All Together When You’re Hypermobile. Her story sheds light on the plight of many disabled people who turn to crowdsourcing for their healthcare when the medical system doesn’t serve them well.

The new book highlights her 17-year journey to getting a correct diagnosis of a once-thought to be rare disorder that wrecked her life as she knew it. She, like many other chronically ill people, has been forced to turn to online forums and fellow patients instead of trained doctors to learn all they can about their diseases, what Cox terms “crowdsourcing your care.” Medical crowdsourcing sites and apps are gaining momentum and are powered by AI, including patient-focused sites like CrowdMed, StuffThatWorks, and PatientsLikeMe.

Initial response by the patient community has been overwhelming with five star reviews rocketing the Amazon new release to #1 in its category and ranked #3 in the free Kindle downloads of the week!

A long-time EDS medical provider, Dr. Alan Spanos, says, “People with EDS, and certain other conditions, are sidelined or completely ignored by the medical profession. For these conditions, patients themselves have to become the experts, then search for the few educable doctors who will take the time to learn from them and have enough interest in them to want to help them. These doctors are a dwindling population, an endangered species, threatened by extinction due to the nature of our health system: a profit-based industry rather than a community service.”

In her book, Cox outlines why medical researchers now believe at least 1 in every 500 people is afflicted by hypermobile EDS, often going undiagnosed (average time to diagnosis: 12–14 years). The multi-systemic nature of EDS is rooted in a genetic abnormality causing faulty collagen, which is found everywhere in the body and can prove elusive to many medical professionals today. This can complicate connecting the uncorrelated symptoms previously only recognized by hyperextending skin and joints.

Cox explains to patients and their caregivers who are looking for help not only the basics of hypermobility but also its common comorbidities, such as autonomic dysfunction of dysautonomia or POTS (similar to long-COVID) and joint instability, such as craniocervical issues, which happen when your brain drops into your spinal canal and causes mild Chiari. All of these side effects are ones that Cox herself experiences. Her passion project in writing this book has been to collect guidance from other patients and community members to share resources along with suggestions to get diagnosed, potential provider specialists and treatment options, plus lifestyle management tips to enhance quality of life.

“I believe in self-advocacy and was graciously joined by others in this joint effort with doctors, advocates, and scientists on the edge of research to bring this patient community resource to life.” Cox says the result is a powerful guide with insights from medical professionals who understand the disease and advocacy leaders who support research into potential testing, treatment, and hope for a cure. Many patients long for these needed resources that could change the dismissive approach many doctors have to invisible illnesses like EDS. Patients empowered to help other patients.

Cox was joined by the below list of distinguished medical experts, including researchers investigating the disorder at the Medical University of South Carolina (MUSC). Working together, they aim to help make a difference.


  • Dr. Sunil Patel, Neurosurgery Chief (MUSC)
  • Dr. “Chip” Norris, The Norris Lab (researching hypermobile Ehlers Danlos Syndrome (hEDS)), MUSC
  • Dr. Cortney Gensemer PhD, Norris Lab (inspiration behind the lab and has hEDS)
  • Dr. Amanda Miller, Progress Physical Therapy (specialty in hypermobility)
  • Dr. Eric Singman, Former Chief of the Wilmer Eye Institute at Johns Hopkins and Professor of Ophthalmology and Neuro-ophthalmology at the University of Maryland Medical School

Cox was joined by a number of community leaders who worked to get information directly into the hands of patients who were looking for answers.

  • Lauren Stiles, Dysautonomia International’s President and Co-Founder
  • Lara Bloom, President, The Ehlers Danlos Society
  • Dorothy Poppe, President, Bobby Jones Chiari & Syringomyelia Foundation
  • Gwenn Herman, Clinical Director, US Pain Foundation
  • Trisha Torrey,Founder, The Alliance of Professional Health Advocates
  • Camille Schrier, Miss America 2020 (who has EDS)
  • Ben Glass, Long-term disability lawyer, Ben Glass Law

Share article on social media or email:

Janet Louise Adler’s newly released “A Peek at Heaven” is a vividly…


“A Peek at Heaven” from Christian Faith Publishing author Janet Louise Adler is a compelling retelling of the author’s experience with a great vision of Heaven following complications with surgery.

(PRWeb August 11, 2022)

Read the full story at https://www.prweb.com/releases/janet_louise_adlers_newly_released_a_peek_at_heaven_is_a_vividly_detailed_account_of_a_deeply_personal_spiritual_experience/prweb18832921.htm

The Journey from ‘I Do’ to ‘Well Done!’” is a thoughtful and informative discussion of marriage


News Image

“Transformation: The Journey from ‘I Do’ to ‘Well Done!’”: a heartfelt look into the highs and lows of marriage. “Transformation: The Journey from ‘I Do’ to ‘Well Done!’” is the creation of published author Mishay Lavine, a certified biblical counselor and widow who seeks to help encourage strong marriages.

Lavine shares, “are you ready for marriage? Preparation for a wife’s big day includes the dresses, flowers, venues, invitations, cake, and of course, the rings. After the big day comes preparation for a lifetime of transformations; and unfortunately, the process can really take one by surprise. After the ceremony is concluded, the guests have shared gifts and returned to their individual lives and spaces, now what? There is help for every stage of the marriage process of becoming one flesh like the Holy Bible teaches. As each person relinquishes singleness to unite as one, for both husbands and wives, transformations must occur. As these adjustments commence, there is a sure model by which every wife can mold her service to her husband from ‘I Do’-2-‘Well Done!’

“The responsibilities of being married and a parent all within a two-day process required responses and adjustments that the author never considered necessary. Where does one turn for the right answers? Contained here are Biblical answers to questions, challenges, and false expectations that were experienced early in the author’s marriage. Difference of opinions and unrealistic expectations resulted in a plethora of disputes between the happy couple; what appeared to work for Hollywood marriages and on television exacerbated the chaos between two strong-willed individuals, predominantly where the wife was determined to have things her way.

“There is hope! With faith, prayer, humility, and practice, transformations for this union resulted in a seamless ‘happily-ever-after’ bond until, at the end of life’s journey, honoring their vow to GOD, the two did part. Every marriage will experience transitions from the day ‘I Do’ is promised until death separates the two; however, healthy transformations are the outcomes when the applied model is Biblical.

“There is hope and a model for the ‘happily ever after’ couples long to experience. Mrs. Lavine’s transparency is evidence that it is possible. Shine On…from ‘I Do’-2-‘Well Done!’”

Published by Christian Faith Publishing, Mishay Lavine’s new book is a helpful resource for those looking to explore ways to support their spouse.

Lavine offers personal reflection and relevant scripture in hopes of empowering others to put in the necessary work to achieve successful, long-lasting marriages.

Consumers can purchase “Transformation: The Journey from ‘I Do’ to ‘Well Done!’” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “Transformation: The Journey from ‘I Do’ to ‘Well Done!’,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

Brother Melvin’s newly released “Jealous for You: An Exposé of…


“Jealous for You: An Exposé of the Love of God” from Christian Faith Publishing author Brother Melvin is a thought-provoking analysis of God’s plan and the special connection with mankind that is…

(PRWeb August 11, 2022)

Read the full story at https://www.prweb.com/releases/brother_melvins_newly_released_jealous_for_you_an_expose_of_the_love_of_god_is_a_compelling_discussion_of_gods_commitment_to_mankind/prweb18832929.htm

University Cancer & Blood Center adds radiation oncologist to physician roster


Dr. Cole Steber is now seeing patients at University Cancer & Blood Center’s Radiation Oncology Clinic in Athens

“It’s an honor for me to help guide a patient through treatment, using the latest technology and instilling hope along the way,” says Dr. Cole Steber, University Cancer & Blood Center.

University Cancer & Blood Center (UCBC), a leading oncology and hematology practice for Northeast Georgia, welcomes Dr. Cole Steber, a board-certified clinical and radiation oncologist. This continues UCBC’s tradition of enlisting best-in-class physicians to deliver the highest possible patient care.

Dr. Steber is now seeing patients at the UCBC Athens-Clarke County Radiation Oncology Clinic (220 Hawthorne Park, Athens). He joins UCBC’s expert team, specializing in the radiation therapy treatment of patients who have a wide variety of cancers. Like all of UCBC’s radiation oncologists, Dr. Steber works closely with medical oncologists, surgeons, and other doctors to coordinate the most appropriate care for each patient. Radiation therapy uses carefully targeted and regulated doses of high-energy radiation to kill cancer cells.

“Dr. Steber exemplifies all of the qualities we look for in a radiation oncologist,” says Dr. Petros G. Nikolinakos, Managing Partner and Director of Clinic Research. “He’s caring, intuitive, and highly skilled. We’re thrilled to have him on board, and he’s already making a difference in the lives of our patients.”

After earning his Doctor of Medicine degree from the University of Kentucky College of Medicine in Lexington, Ky., Dr. Steber completed his residency at the Wake Forest School of Medicine where he served as chief resident from 2020-2021. He is a member of the American Society for Radiation Oncology, American Society for Clinical Oncology, and American Board of Radiology.

“The passion I have for my work is personal,” says Dr. Steber. “My mother is a cancer survivor, and I know firsthand the toll this disease can take on a patient and their family. That’s why it’s an honor for me to help guide a patient through treatment, using the latest technology and instilling hope along the way.”

Radiation oncology appointments can be made by visiting UniversityCancer.com or by calling (706) 548-0500.

About UCBC

University Cancer & Blood Center has been Northeast Georgia’s leading cancer and hematology treatment center for over 40 years. Our highly skilled medical professionals, whose backgrounds include working at the nation’s leading cancer centers, provide every patient with the most advanced cancer care available in an atmosphere of care and compassion. For more information, visit universitycancer.com or call (706) 353-2990.

Share article on social media or email:

Study Funded by the Rett Syndrome Research Trust Demonstrates First-Ever Symptom Improvement in a Mouse Model of Any Human Disease Using RNA Editing


Our singular goal at RSRT is to accelerate a cure for Rett syndrome. Showing that RNA editing is a powerful strategy to achieve that goal means we are one step closer to fulfilling our mission.

This week the Proceedings of the National Academy of Sciences published a paper online demonstrating that RNA editing can improve symptoms in a mouse model of Rett syndrome, a rare and severe neurological disorder. This is the first published study to demonstrate symptomatic improvement in a mouse model of any human disease by RNA editing, and the study provides an essential proof of concept for improving Rett syndrome symptoms using RNA editing.

The study was authored by Gail Mandel, PhD, and post-doctoral fellow John Sinnamon, PhD, of Oregon Health and Science University. During the span of a decade, the Rett Syndrome Research Trust (RSRT) has provided $3.2 million to the Mandel lab for this study and others related to the functioning of the MECP2 gene, which, when mutated, causes Rett syndrome.

“I am so proud to recognize Dr. Mandel, Dr. Sinnamon, and everyone in the Mandel lab for this important publication,” said RSRT CEO Monica Coenraads. “Our singular goal at RSRT is to accelerate a cure for Rett syndrome. Showing that RNA editing is a powerful strategy to achieve that goal means we are one step closer to fulfilling our mission.”

“We hope our proof-of-concept studies in mouse models of Rett syndrome will encourage studies by others to continue to advance the field rapidly toward a cure for Rett syndrome and other neurological diseases,” said Dr. Mandel. “In addition to the many other investigators before us who first discovered natural RNA editing and developed targeted RNA editing strategies, we owe particular thanks to Dr. Joshua Rosenthal of Marine Biological Laboratories in Woods Hole, Massachusetts, who introduced us to his Editase system that we adapted to repair MECP2 mutations.”

Rett syndrome is caused by mutations in MECP2, a gene located on the X chromosome. Rett syndrome affects 350,000 individuals worldwide, most of whom are female. The symptoms of Rett are devastating, including losing acquired skills such as walking, talking, and hand use, and symptoms such as scoliosis, extreme anxiety, tremors, seizures, hyperventilation, and digestive problems. Most people with Rett syndrome live into adulthood, requiring round-the-clock care.

RNA editing, one of six genetic-based curative strategies being pursued by RSRT, is a naturally occurring process in human cells. A group of enzymes called Adenosine Deaminase Acting on RNA (ADARs) changes the RNA base adenosine (A) to inosine (I), which is interpreted by the cell as guanosine (G). The editing of A-to-I(G) in RNA then causes coding changes in the resulting protein, altering protein function.

Using a newly developed mouse model of Rett syndrome containing a patient mutation, the authors injected into the bloodstream an adeno-associated virus (AAV) encoding an engineered ADAR enzyme, referred to as Editase, and a guide RNA, which acts like a GPS, that brings the enzyme to the correct spot in the mouse Mecp2 RNA. After injection of virus into young male Rett mice, they observed editing in multiple brain regions, with the highest amount of editing, 18%, in the brainstem. Looking at individual cells in the brainstem, about 20% of cells showed repair of MeCP2 protein, and the repaired protein was expressed to, on average, 70% of normal levels. Importantly, some cells even showed protein levels equal to those observed in wildtype cells, indicating that there is no inherent ceiling to the level of repair that is possible in vivo.

Many of the Rett-like behaviors involve multiple brain regions, or the specific neuronal circuits underlying the behavior are not well defined. However, the brainstem, which is the region with the highest level of MECP2 RNA editing, is known to be essential for the control of respiration, and respiratory dysfunction is a hallmark symptom of Rett syndrome patients that is repeated in Rett mice. Untreated mutant male mice and those injected with the Editase and a guide RNA that did not target Mecp2 messenger RNA showed an expected high number of apneas and irregular breathing patterns. However, the mutant male mice injected with a virus targeting Mecp2 RNA had the same number of apneas and breathing pattern as untreated normal mice.

Importantly, Dr. Mandel and her colleagues identified a limiting factor to maximizing editing of cells in the brain: expression of the guide RNA that targets the Editase enzyme to MECP2 RNA. While both the Editase and guide RNA were packaged in the same virus, the pattern of expression of these two essential components was inconsistent across different brain regions, with the brainstem showing the most cells showing expression of both enzyme and guide. This key finding is relevant for all guide-based therapies used in the brain, including DNA base editing, which typically uses the same viral component as this study to express guide RNAs. Improvements in the design of the virus will likely result in more cells exhibiting guide RNA expression and a correspondingly higher number of cells showing MeCP2 repair.

“Targeted RNA editing is another prime example of applying the knowledge gained from basic science research to develop therapeutic approaches for human disease. This study is the culmination of a multi-study project to test the feasibility of utilizing RNA editing to repair the mutations that cause Rett syndrome,” said Dr. Sinnamon. “We hope our work will continue to drive interest in RNA editing technology and the underlying biology, and ultimately result in a cure for diseases, including Rett syndrome. We are grateful to the Rett Syndrome Research Trust for recognizing the potential of our work and to the larger Rett syndrome community for their support.”

This study is the first demonstration of symptomatic improvement in a mouse model of human disease by RNA editing and provides an essential proof of concept for improving Rett syndrome symptoms using RNA. Potentially 45% of Rett syndrome mutations are repairable by RNA editing, including the common mutations R168X, R255X, R270X, and R294X. Now that it has been established that RNA can affect symptoms in models of Rett, future studies can focus on improving the efficiency of editing and of symptom rescue in models of these mutations.

Dr. Mandel and Dr. Sinnamon were the first researchers to pursue RNA editing for Rett after receiving funding through the organization’s MECP2 Consortium. Encouraging progress by the RSRT-funded Mandel lab catalyzed the launch in late 2019 of Vico Therapeutics. Dr. Mandel is a scientific co-founder of the company and a champion for the Rett syndrome program.

ABOUT THE RETT SYNDROME RESEARCH TRUST

RSRT is a nonprofit organization with a highly personal and urgent mission: achieving a cure for Rett syndrome and related disorders caused by defects in the MECP2 gene. Since its founding in 2008, RSRT has awarded $64 million, more than any other Rett organization in the world, to leading scientists pursuing targeted research on Rett. RSRT funds and spearheads global scientific and clinical activities advancing the most promising curative approaches. To date, every biopharmaceutical company pursuing a cure for Rett syndrome is doing so because they leveraged discoveries and resources incubated with RSRT funding. A highly efficient nonprofit, RSRT has spent an average of 95 percent of every dollar on its research program. To learn more, please visit http://www.reverserett.org.

Memorial Cardiac and Vascular Institute Adds Cardiologists to its Physician Roster


Dr. Adetola Ladejobi

“The capabilities, accomplishments, and diverse backgrounds of these physicians will enhance Memorial’s offerings as an academic medical center, on par with larger, university-based systems,” said Dr. Michael Cortelli, chief of the Memorial Cardiac and Vascular Institute.

Memorial Healthcare System, a South Florida-based academic medical center, has added a diverse trio of cardiologists to its cardiac care team. The fellowship-trained physicians have all worked internationally during their medical careers and join Memorial Cardiac and Vascular Institute as it grows its research and academic programs.

  • – – Adetola Ladejobi, MD, an electrophysiologist, comes to Memorial from the Mayo Clinic, where he completed two fellowships and was an instructor at its college of medicine. Dr. Ladejobi is focused on patient care, research, quality improvement, and healthcare operations. A native of Nigeria, “Tola” earned a master’s degree in public health from Harvard University and has also worked as a strategic consultant to healthcare systems, insurance companies, and Fortune 100 companies.
  • – – Lynda Otalvaro, MD, a clinical cardiologist, was most recently at the University of Florida where she was an assistant professor at UF’s College of Medicine and director of its Lipid Clinic. In the time prior to that, Dr. Otalvaro worked as an adult non-invasive cardiologist in Kentucky. She finished first in her class at Universidad Libre, School of Medicine in Cali, Colombia before coming to the University of Miami’s Miller School of Medicine. While at UM, Dr. Otalvaro completed an internal medicine residency and fellowship in cardiology.
  • – – Sarah Rosanel, MD, completed both an internal medicine residency and cardiovascular disease fellowship at Maimonides Medical Center in Brooklyn, NY. A clinical cardiologist, Dr. Rosanel earned degrees from the Israel Institute of Technology’s Technion American Medical School and Yeshiva University in New York.

“The capabilities, accomplishments, and diverse backgrounds of these physicians will

enhance Memorial’s offerings as an academic medical center, on par with larger, university-based systems,” said Dr. Michael Cortelli, chief of the Memorial Cardiac and Vascular Institute. “Their clinical, research, and academic expertise will benefit our patients and doctors alike.”

Memorial’s Cardiac & Vascular Institute is a cardiovascular care leader, offering a wide array of services dedicated to the prevention, detection, and treatment of cardiovascular disease. Its multi-disciplinary specialists collaborate using sophisticated diagnostic equipment and facilities. Physician-review panels and nurses regularly review cardiovascular care outcomes to ensure quality assurance that utilizes computerized data collection.

With extraordinary medical expertise, advanced technology and exacting quality guidelines, Memorial Cardiac & Vascular Institute offers a superior level of cardiovascular care.

To learn more and/or make an appointment, visit our website or call 954-276-5500.

                                                                                     # # #

Share article on social media or email: